Role of cytotoxic T-lymphocyte-mediated immune selection in a dominant human leukocyte antigen-B8-restricted cytotoxic T-lymphocyte epitope in nef

Journal of Acquired Immune Deficiency Syndromes

Volumn 48, Issue 2, 2008, Pages 133-141

  Maurer, Katja ^a   Harrer, Ellen G ^a   Goldwich, Andreas ^a   Eismann, Kathrin ^a   Bergmann, Silke ^a   Schmitt Haendle, Matthias ^a   Spriewald, Bernd ^a   Mueller, Sandra M ^a   Harrer, Thomas ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Cytotoxic T lymphocytes; Epitope; HIV 1; Human leukocyte antigen B8; Immune selection

Indexed keywords

EPITOPE; GAMMA INTERFERON; HLA B8 ANTIGEN; NEF PROTEIN; PHENYLALANYLLEUCYLLYSYLGLUTAMYLLYSYLGLYCYLGLYCYLLEUCINE; TRYPTOPHYLPROLYLALANYLISOLEUCYLARGINYLGLUTAMYLARGINYLMETHIONINE; UNCLASSIFIED DRUG; NEF PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS 1;

ADULT; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CORRELATIONAL STUDY; CYTOTOXIC T LYMPHOCYTE; DISEASE COURSE; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; GENE MUTATION; GENE SEQUENCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; LONGITUDINAL STUDY; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MOLECULAR RECOGNITION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIREMIA; VIRUS LOAD; ACQUIRED IMMUNE DEFICIENCY SYNDROME; CD4 LYMPHOCYTE COUNT; CHEMISTRY; IMMUNOLOGY; MIDDLE AGED; MOLECULAR GENETICS; MUTATION; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; VIROLOGY;

ACQUIRED IMMUNODEFICIENCY SYNDROME; BASE SEQUENCE; CD4 LYMPHOCYTE COUNT; EPITOPES, T-LYMPHOCYTE; FEMALE; HLA-B8 ANTIGEN; HUMANS; IMMUNODOMINANT EPITOPES; LONGITUDINAL STUDIES; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION; NEF GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; T-LYMPHOCYTES, CYTOTOXIC; VIRAL LOAD;

EID: 46449124292     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e31816fdc4a     Document Type: Article

References (28)

1. Koup RA, Safrit JT, Cao Y, et al. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J Virol. 1994;68:4650-4655.
2. Harrer T, Harrer E, Kalams SA, et al. Cytotoxic T lymphocytes in asymptomatic long-term nonprogressing HIV-1-infection. Breadth and specificity of the response and relation to in vivo viral quasispecies in a person with prolonged infection and low viral load. J Immunol. 1996; 156:2616-2623.
3. Harrer T, Harrer E, Kalams SA, et al. Strong cytotoxic T-cell and weak neutralizing antibody responses in a subset of persons with stable nonprogressing HIV type 1 infection. AIDS Res Hum Retroviruses. 1996; 12:585-592.
4. Musey L, Hu Y, Eckert L, et al. HIV-1 induces cytotoxic T lymphocytes in the cervix of infected women. J Exp Med. 1997;185:293-303.
5. Schmitz JE, Kuroda MJ, Santra S, et al. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science. 1999; 283:857-860.
6. Klein MR, van Baalen CA, Holwerda AM, et al. Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1-infection: a longitudinal analysis of rapid progressors and long-term asymptomatics. J Exp Med. 1995;181:1365-1372.
7. Betts MR, Ambrozak DR, Douek DC, et al. Analysis of total human immunodeficiency virus (HIV)-specific CD4(+) and CD8(+) T-cell responses: relationship to viral load in untreated HIV infection. J Virol. 2001;75:11983-11991.
8. Price DA, Goulder PJ, Klenerman P, et al. Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection. Proc Natl Acad Sci USA. 1997;94:1890-1895.
9. Barouch DH, Kunstman J, Kuroda MJ, et al. Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes. Nature. 2002;415:335-339.
10. Friedrich TC, Dodds EJ, Yant LJ, et al. Reversion of CTL escape-variant immunodeficiency viruses in vivo. Nat Med. 2004;10:275-281.
11. Moore CB, John M, James IR, et al. Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level. Science. 2002; 296:1439-1443.
12. Blankson JN, Bailey JR, Siliciano RF. Crosscurrents in HIV-1 evolution. Nat Immunol. 2006;7:121-122.
13. Brander C, Hartman KE, Trocha AK, et al. Lack of strong immune selection pressure by the immunodominant, HLA-A*0201-restricted cytotoxic T lymphocyte response in chronic human immunodeficiency virus-1 infection. J Clin Invest. 1998;101:2559-2566.
14. Addo MM, Yu XG, Rathod A, et al. Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation toviral load. J Virol. 2003;77:2081-2092.
15. Draenert R, Verrill CL, Tang Y, et al. Persistent recognition of autologous virus by high-avidity CD8 T-cells in chronic, progressive human immunodeficiency virus type 1 infection. J Virol. 2004;78:630-641.
16. Lieberman J, Shankar P, Manjunath N, et al. Dressed to kill? A review of why antiviral CD8 T lymphocytes fail to prevent progressive immunodeficiency in HIV-1-infection. Blood. 2001;98:1667-1677.
17. Trautmann L, Janbazian L, Chomont N, et al. Upregulation of PD-1 expression on HIV-specific CD8(+) T-cells leads to reversible immune dysfunction. Nat Med. 2006;12:1198-1202.
18. Kiepiela P, Leslie AJ, Honeyborne I, et al. Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA. Nature. 2004; 432:769-775.
19. Dong T, Stewart-Jones G, Chen N, et al. HIV-specific cytotoxic T-cells from long-term survivors select a unique T-cell receptor. J Exp Med. 2004; 200:1547-1557.
20. HIV Database [database online]. Los Alamos, NM: Los Alamos National Laboratory; 2005. Updated April 27, 2007.
21. Altfeld M, Rosenberg ES, Shankarappa R, et al. Cellular immune responses and viral diversity in individuals treated during acute and early HIV-1-infection. J Exp Med. 2001;193:169-180.
22. Oxenius A, Price DA, Easterbrook PJ, et al. Early highly active antiretroviral therapy for acute HIV-1-infection preserves immune function of CD8+ and CD4+ T lymphocytes. Proc Natl Acad Sci USA. 2000;97:3382-3387.
23. Schmitt M, Harrer E, Goldwich A, et al. Specific recognition of lamivudine-resistant HIV-1 by cytotoxic T lymphocytes. AIDS. 2000;14:653-658.
24. Goulder PJ, Reid SW, Price DA, et al. Combined structural and immu-nological refinement of HIV-1 HLA-B8-restricted cytotoxic T lymphocyte epitopes. Eur J Immunol. 1997;27:1515-1521.
25. Goulder P, Price D, Nowak M, et al. Co-evolution of human immunodeficiency virus and cytotoxic T-lymphocyte responses. Immunol Rev. 1997;159:17-29.
26. da Silva J. The evolutionary adaptation of HIV-1 to specific immunity. Current HIV Research. 2003;1:363-371.
27. Frahm N, Kiepiela P, Adams S, et al. Control of human immunodeficiency virus replication by cytotoxic T lymphocytes targeting subdominant epitopes. Nat Immunol. 2006;7:173-178.
28. Meyer-Olson D, Brady KW, Bartman MT, et al. Fluctuations of functionally distinct CD8+ T-cell clonotypes demonstrate flexibility of the HIV-specific TCR repertoire. Blood. 2006;107:2373-2383.